Antares Pharma reported $127.96M in Current Assets for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Adamas Pharmaceuticals ADMS:US 108M 7.65M
Adma Biologics ADMA:US $ 174.78M 3.43M
Aerie Pharmaceuticals AERI:US $ 275.95M 13.07M
Ani Pharmaceuticals ANIP:US $ 191.38M 415K
Atrion ATRI:US 133.77M 7.94M
Becton, Dickinson and BDX:US $ 8838M 700M
Biodelivery Sciences International BDSI:US $ 188.26M 7.8M
Cara Therapeutics CARA:US $ 171.5M 7.03M
Cerus CERS:US $ 178.05M 7.54M
Eli Lilly And LLY:US $ 17808.3M 512.8M
Endo International Ordinary Shares ENDP:US $ 2748.95M 179.62M
Horizon Pharma HZNP:US $ 2413.92M 238.54M
JAZZ PHA JAZZ:US $ 2628.23M 325.74M
Orasure Technologies OSUR:US $ 289.23M 4.18M
Pacira Pharmaceuticals PCRX:US $ 822.35M 29.77M
Revance Therapeutics RVNC:US $ 293.88M 60.72M
Rockwell Medical RMTI:US $ 46.08M 6.32M
Sientra SIEN:US 146.78M 4.76M
Staar Surgical STAA:US $ 263.94M 15.83M
Supernus Pharmaceuticals SUPN:US $ 668.38M 29.13M
Teva Pharmaceutical TEVA:IT 12.15B 668M
Teva Pharmaceutical Industries TEVA:US $ 12154M 668M
Utah Medical Products UTMD:US $ 75.85M 9.23M
Zogenix ZGNX:US $ 375.46M 40.93M